AXQ Capital’s Organon & Co OGN Stock Holding History

AXQ Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,532	Closed	-$93K	–	1246
2026 Q1	$93K	Buy	+15,532	New	+$117K	0.01%	877
2025 Q2	–	Sell	-40,459	Closed	-$602K	–	720
2025 Q1	$602K	Buy	+40,459	New	+$622K	0.24%	139
2024 Q4	–	Sell	-32,503	Closed	-$622K	–	574
2024 Q3	$622K	Buy	+32,503	New	+$674K	0.19%	215
2023 Q4	–	Sell	-21,500	Closed	-$373K	–	764
2023 Q3	$373K	Buy	+21,500	New	+$448K	0.13%	267

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

AXQ Capital's OGN Position: Q2 2026 in Review

AXQ Capital sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 15,532 shares — an estimated $93K sold.

AXQ Capital first reported a position in OGN in Q3 2023 and held it in 4 quarters. The position peaked at $622K in Q3 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

AXQ Capital reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 15,532 Organon & Co shares in Q2 2026, an estimated $93K.
AXQ Capital first reported a position in Organon & Co in Q3 2023 and held it in 4 quarters.
AXQ Capital's Organon & Co position peaked at $622K in Q3 2024.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.